![](/img/cover-not-exists.png)
Phase II study of the eortc breast group with vorozole (R 83842), a new non-steroidal aromatase inhibitor in metastatic breast cancer (MBC) — preliminary results
Paridaens, R., Piccart, M., Nooy, M., Klijn, J.G.M., Rubens, R.D., Beex, L., Tomiak, E., Van Vreckem, A., Vinholes, J.Volume:
29
Year:
1993
Language:
english
DOI:
10.1016/0959-8049(93)91079-Z
File:
PDF, 152 KB
english, 1993